PropertyValue
?:abstract
  • Following acute infection, individuals COVID-19 may still shed SARS-CoV-2 RNA. However, limited information is available regarding the active shedding period or whether infectious virus is also shed. Here, we monitored the clinical characteristics and virological features of 38 patients with COVID-19 (long-term carriers) who recovered from the acute disease, but still shed viral RNA for over 3 months. The median carrying history of the long-term carriers was 92 days after the first admission, and the longest carrying history was 118 days. Negative-positive viral RNA-shedding fluctuations were observed. Long-term carriers were mostly elderly people with a history of mild infection. Infectious SARS-CoV-2 was isolated from the sputum, where high level viral RNA was found. All nine full-length genomes of samples obtained in March–April 2020 matched early viral clades circulating in January–February 2020, suggesting that these patients persistently carried SARS-CoV-2 and were not re-infected. IgM and IgG antibodies and neutralizing-antibody profiles were similar between long-term carriers and recovered patients with similar disease courses. In summary, although patients with COVID-19 generated neutralizing antibodies, they may still shed infectious SARS-CoV-2 for over 3 months. These data imply that patients should be monitored after discharge to control future outbreaks.
is ?:annotates of
?:creator
?:doi
?:doi
  • 10.1080/22221751.2020.1852058
?:journal
  • Emerging_microbes_&_infections
?:license
  • cc-by
?:pdf_json_files
  • document_parses/pdf_json/4718900bcda5e8023255fc4dfdb1071369f7cb43.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7734137.xml.json
?:pmcid
?:pmid
?:pmid
  • 33196399.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Medline; PMC
?:title
  • Prolonged shedding of severe acute respiratory syndrome coronavirus 2 in patients with COVID-19
?:type
?:year
  • 2020-12-10

Metadata

Anon_0  
expand all